Tranexamic Acid Use and Blood Loss in Total Hip Arthroplasty

NCT02989155 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 576

Last updated 2017-01-20

No results posted yet for this study

Summary

The purpose of this study is to determine the need for a blood transfusion during surgery and to evaluate the levels of certain proteins in the blood when given tranexamic acid.

Conditions

  • Tranexamic Acid Use
  • Blood Loss

Sponsors & Collaborators

  • Ohio State University

    lead OTHER

Principal Investigators

  • Nicoleta Stoicea, MD, PhD · Ohio State University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02989155 on ClinicalTrials.gov